Our Mission
At Design-Zyme LLC, we are developing new carbohydrate-based adjuvants for effective oral and mucosal delivery of next-generation vaccines. Our adjuvanting strategies are coupled with our Lyme disease and Chlamydia vaccine development efforts to create best in class vaccines.
Our Story
​
​
Our journey at Design-Zyme LLC began as a mission to advance human health monitoring strategies and their practical applications. This pioneering work resulted in a general strategy for the in vitro glycosylation of proteins, originally developed to enhance enzyme stability in biosensor fabrication. This patented glycosylation technology also proved invaluable for attaching carbohydrate adjuvants to protein-based vaccines.
​
Today, we are at the forefront of vaccine innovation, crafting modular, multi-epitope, self-assembling formulations that feature a covalently attached adjuvant. Our ongoing research is dedicated to developing novel vaccines with enhanced effectiveness against infectious pathogens.
​
Our ultimate goal is to reshape the vaccine industry by perfecting the oral and mucosal delivery of next-generation vaccines. Guided by our team of seasoned scientists and researchers, we are committed to creating best-in-class vaccines tailored to combat diseases like Lyme disease and Chlamydia. At Design-Zyme, we believe in making a positive impact on global health and are unwavering in our dedication to pioneering innovative research that truly makes a difference. Join us in our mission to create a healthier world.
At Design-Zyme LLC, our team is made up of experienced leaders in the biotechnology industry. Our researchers and scientists have a passion for creating innovative solutions to global health problems. We are committed to making a difference in the world through our research and development of next-generation vaccines.
